Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,406 | -14,601 | -9,499 | -6,780 | -4,639 |
| Depreciation Amortization | -143 | -45 | -772 | -446 | -374 |
| Other Working Capital | 223 | -262 | -182 | -374 | -444 |
| Other Operating Activity | 8,798 | 12,331 | 2,468 | 1,863 | 1,401 |
| Operating Cash Flow | $-5,528 | $-2,577 | $-7,985 | $-5,736 | $-4,055 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -4 | -50 | -47 | -2 |
| Other Investing Activity | 118 | 33 | 896 | 583 | 523 |
| Investing Cash Flow | $104 | $29 | $846 | $536 | $521 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,841 | 23,933 | 12,341 | 6,584 | 27 |
| Financing Cash Flow | $24,841 | $23,933 | $12,341 | $6,584 | $27 |
| Beginning Cash Position | 18,688 | 18,688 | 13,487 | 13,487 | 13,487 |
| End Cash Position | 38,105 | 40,073 | 18,688 | 14,871 | 9,979 |
| Net Cash Flow | $19,417 | $21,385 | $5,202 | $1,385 | $-3,507 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,528 | -2,577 | -7,985 | -5,736 | -4,055 |
| Capital Expenditure | -14 | -4 | -50 | -47 | -2 |
| Free Cash Flow | -5,542 | -2,580 | -8,035 | -5,783 | -4,057 |